• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
Shop

Celebrities Continue to Come Out for Psychedelics

Jason Najum by Jason Najum
October 21, 2021
in Culture
Reading Time: 2 mins read
A A
Celebrities Continue to Come Out for Psychedelics

Like a growing snowball rolling merrily down the hill; like a chorus of voices given permission by that first brave soul — public figures are continuing to come out about their psychedelic experiences.

Feeling empowered by the growing public support and diminishing social stigma, a steady stream of celebrities are opening up about mental health and the positive effects of psychedelics on their lives.

Today, world-renowned author Micheal Pollan is on The Daily Show discussing his experiences researching and trying psychedelics for his book “This Is Your Mind on Plants”. The subtle spillover effect of someone universally respected like Mr. Pollan openly touting the potential benefits of psychedelics cannot be overstated.

Had a stimulating conversation with Trevor Noah about psychedelics on @TheDailyShow – on tonight! https://t.co/sKjmICZw1U

— Michael Pollan (@michaelpollan) October 22, 2021

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

Continue on your trip...

Childhood Trauma’s Role in Men’s Substance Use Disorders

Human-Centered AI in Healthcare

After the Billion-Dollar Psychedelic Bet: Who’s Next for Big Pharma?

On the same day we have Maclean’s, Canada’s most prestigious news magazine, coming out with a feature on Mark Messier — one of the country’s most respected athletes — and in the headline he discusses his positive experiences with magic mushrooms.

“Obviously it turned out to be an amazing experience, but more important was the question afterwards: wow, how can I use my mind to empower myself to be a better player, to be a better person, to have more energy”

 

Purchase Fast Lasix

The hockey icon talks with @mariedanielles about mental health, hockey violence—and what he’ll do when the New York Rangers call https://t.co/UQRZSqHe65

— Maclean’s Magazine (@macleans) October 21, 2021

 

 

This positive news follows the recent headlines about Hollywood superstar Will Smith and his life-changing experience with ayahuasca. The actor opened up about how “more than a dozen ayahuasca rituals” allowed him “a fresh sampling of the fruits of the human experience.”

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

Presenting GQ’s November cover star: Will Smith. Read the full story by @WesleyLowery here: https://t.co/1lIiNMtI1Q pic.twitter.com/QviHDeahtV

— GQ Magazine (@GQMagazine) September 27, 2021

 

And let’s not forget billionaire futurist and Twitter kingmaker Elon Musk coming out in favor of a world that accepts and integrates psychedelics. See our coverage here.

All of this is added to other celebrities coming out about their journeys, and athletes like Mike Tyson and Lamar Odom praising plant medicine for drastically changing their lives for the better (ps: you can see these two superstars at Microdose’s Wonderland conference next month)

Awesome news. Keep exploring and keep being brave. We’re almost there.

Tags: celebritypsychedelics
Jason Najum

Jason Najum

Jason Najum's work has appeared in many industry-leading publications, covering topics ranging from cleantech start-ups to travel and culture. He's currently Microdose's Managing Editor and Senior Writer. Write him at jason@microdose.buzz and see his work at www.jasonnajum.com

Next Post
Small Pharma On a Roll With Price Surge and Major Milestones

Small Pharma On a Roll With Price Surge and Major Milestones

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.